CD

CHARLES DUJON

2359 STRATEGIES · Washington, DC · registered since 2024
Registered · LDAActive

Background

Government experience
Legislative Director (1998-2013)
Rep. Jesse Jackson, Jr.
Disclosed on LD-2 filings
Leg. Dir. US House
Disclosed on LD-2 filings
Legislative Director
U.S. House of Representatives
Disclosed on LD-2 filings
Career
Washington, DC
2024 - present

Specific issues

Congressionally Directed Medical Research
Defense · 2024 Q4
Stephanie Tubbs Jones Uterine Fibroid Research and Education Act Menstrual Health Awareness Month
Health Issues · 2024 Q4
American Innovation and Choice Online Act (AICOA) Open App Markets Act (OAMA)
Communications/Broadcasting/Radio/TV · 2024 Q4
American Innovation and Choice Online Act (AICOA) Open Apps Market Act (OAMA)
Labor Issues/Antitrust/Workplace · 2024 Q4
Homeland Appropriations (CISA) Commerce, Justice, Science Appropriations (ITC) Financial Services and General Govt. Appropriations (FTC)
Budget/Appropriations · 2024 Q4
Open App Markets Act (OAMA) American Innovation and Choice Online Act (AICOA)
Computer Industry · 2024 Q4

Clients

$██,███ / qtrUnlock
2024 · 4 filings
$██,███ / qtrUnlock
2024 · 4 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock

Filing history

2024 Q4
TRAVERE THERAPEUTICS
Q4lda.gov →
2024 Q4
FEDERAL STREET STRATEGIES LLC
Q4lda.gov →
2024 Q4
THE FIBROID FOUNDATION
Q4lda.gov →
2024 Q3
THE FIBROID FOUNDATION
Q3lda.gov →
2024 Q3
FEDERAL STREET STRATEGIES LLC
Q3lda.gov →
2024 Q3
TRAVERE THERAPEUTICS
Q3lda.gov →
2024 Q2
TRAVERE THERAPEUTICS
Q2lda.gov →
2024 Q2
FEDERAL STREET STRATEGIES LLC
Q2lda.gov →
2024 Q2
THE FIBROID FOUNDATION
Q2lda.gov →
2024 Q1
FEDERAL STREET STRATEGIES LLC
1Alda.gov →
2024 Q1
TRAVERE THERAPEUTICS
Q1lda.gov →
2024 Q1
THE FIBROID FOUNDATION
Q1lda.gov →
Showing recent filings · full history on lda.gov